A 67-year-old female patient from New York with a long history of fatigue, joint and muscle pain, rash and fevers is scheduled to see the rheumatologist in five days. She is referred to the rheumatologist by her primary care physician (PCP) for possible diagnosis of lupus erythematosus. The patient requested her medical records from her…
Rheumatology Research Foundation Hosts 10th Annual Investigators’ Meeting in St. Louis
The Rheumatology Research Foundation hosted the 10th Annual Investigators’ Meeting in St. Louis, June 24–25. The meeting provides Foundation-funded investigators an opportunity to learn about recent findings and research projects, network, exchange ideas and collaborate on future projects. More than 30 rheumatology professionals were in attendance, with presentations from 21 investigators. James O’Dell, MD, professor…
Drug Industry on Tenterhooks as Maryland Price-Gouging Law Nears
(Reuters)—As U.S. consumer outrage grows over prescription drug prices, state authorities and patient advocates in Maryland are preparing to enforce the nation’s first law designed to punish drugmaker price-gouging. The Maryland Attorney General’s office said it will field complaints and investigate “unconscionable increases” in essential generic medicines when the closely watched law takes effect Oct….
Demand for Revision Total Knee Arthroplasty Is on the Rise
In the next five to 10 years, the frequency of revision total knee arthroplasty is expected to grow 600%, due to the rise in obesity in the U.S. population and increase in primary knee replacement surgeries. Physicians can use different tools to help decrease the risk of premature implant failure and improve patient outcome…
Obamacare Enrollment to Fall in 2018 and Beyond after Cuts -CBO
NEW YORK (Reuters)—Enrollment on the Obamacare health insurance exchanges in 2018 and later years is expected to be less than previously forecast, dampened by the Trump administration’s decision to pull back enrollment efforts, the U.S. Congressional Budget Office said on Thursday. The administration has cut back on advertising spending, halved the enrollment period to six…
Prosecutors Identify Insys Founder as Unindicted Co-conspirator in Opioid Case
BOSTON (Reuters)—U.S. prosecutors have identified Insys Therapeutics Inc’s billionaire founder as an unindicted co-conspirator in a case accusing six former executives and managers of participating in a scheme that involved bribing doctors to prescribe a fentanyl-based drug, according to a court document. John Kapoor, who stepped down as chief executive of Insys in January, was…
FDA Approves First Biosimilar for the Treatment of Cancer
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the U.S. for the treatment…
Key U.S. Senators Reach Deal on Funding Children’s Health Program
WASHINGTON (Reuters)—Leaders of the U.S. Senate Finance Committee said on Tuesday they reached an agreement to finance a federal insurance program for millions of lower-income children and pregnant women that was due to expire at the end of the month. Republican Senator Orrin Hatch, chairman of the finance committee, and the panel’s top Democrat, Senator…
Doctors Who Take Pharmaceutical Money Use Twitter to Hype Drugs
(Reuters Health)—Some cancer doctors use Twitter to promote drugs manufactured by companies that pay them, but they almost never disclose their conflicts of interest on the social media platform, a new study shows. “This is a big problem,” says senior author Dr. Vinay Prasad, a professor at Oregon Health and Science University in Portland. “Doctors…
U.S. Tribal Patent Deal Could Impact Generic Drug Market
(Reuters)—A groundbreaking deal between Allergan Plc. and a Native American tribe to shield the company’s patents in administrative proceedings could also be used be to protect them from challenges in federal court, legal experts say, potentially dealing a blow to generic competition. Allergan said on Friday it had transferred patents on its blockbuster dry eye…
- « Previous Page
- 1
- …
- 358
- 359
- 360
- 361
- 362
- …
- 774
- Next Page »